Label: FEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE tablet, film coated, extended release

  • NDC Code(s): 58602-844-60, 58602-844-66, 58602-844-85
  • Packager: Aurohealth LLC
  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: Abbreviated New Drug Application

Drug Label Information

Updated April 18, 2025

If you are a consumer or patient please visit this version.

  • Drug Facts

    Active ingredients (in each tablet)

    Fexofenadine Hydrochloride USP 180 mg
    Pseudoephedrine Hydrochloride USP 240 mg

  • Purpose

    Antihistamine
    Nasal decongestant

  • Uses

    • temporarily relieves these symptoms due to hay fever or other upper respiratory allergies:
    • runny nose
    • sneezing
    • itchy, watery eyes
    • itching of the nose or throat
    • temporarily relieves nasal congestion due to the common cold, hay fever or other upper respiratory allergies
    • reduces swelling of nasal passages
    • temporarily relieves sinus congestion and pressure
    • temporarily restores freer breathing through the nose
  • Warnings

    Do not use

    • if you have ever had an allergic reaction to this product or any of its ingredients
    • if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional conditions, or Parkinson’s disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product.
    • if you have difficulty swallowing
  • Ask a doctor before use if you have

    • heart disease
    • thyroid disease
    • glaucoma
    • high blood pressure
    • diabetes
    • trouble urinating due to an enlarged prostate gland
    • kidney disease. Your doctor should determine if you need a different dose.
  • When using this product

    • do not take more than directed
    • do not take at the same time as aluminum or magnesium antacids
    • do not take with fruit juices (see Directions)
    • the tablet coating may be seen in the stool (this is normal). Continue to take as directed (see Directions).
  • Stop use and ask a doctor if

    • an allergic reaction to this product occurs. Seek medical help right away.
    • symptoms do not improve within 7 days or are accompanied by a fever
    • you get nervous, dizzy, or sleepless

    If pregnant or breast-feeding, ask a health professional before use.

  • Keep out of reach of children.

    In case of overdose, get medical help or contact a Poison Control Center (1-800-222-1222) right away.

  • Directions

    • do not divide, crush, chew or dissolve the tablet; swallow tablet whole

     adults and children 12 years of age and over
     take 1 tablet with a glass of water every 24 hours on an empty stomach; do not take more than 1 tablet in 24 hours
     children under 12 years of age
     do not use
     adults 65 years of age and older
     ask a doctor
     consumers with kidney disease
     ask a doctor

    Other information

    • safety sealed: do not use if carton is opened or if individual blister units are torn or opened
    • store between 20° and 25°C (68° and 77°F)
    • FDA approved dissolution test specifications differ from USP
  • Inactive ingredients

    cellulose acetate, colloidal silicon dioxide, copovidone, croscarmellose sodium, dibutyl sebacate, ferrosoferric oxide, glyceryl mono- and di-caprylocaprate, hypromellose, lactose monohydrate, microcrystalline cellulose, polyethylene glycol, polyvinyl alcohol-part. hydrolyzed, propylene glycol, shellac, sodium lauryl sulfate, stearic acid, talc and titanium dioxide

    Questions or Comments?

    call 1-855-274-4122 (Monday - Friday 8:30 AM to 5:00 PM EST)

    Manufactured for:
    AUROHEALTH LLC
    279 Princeton-Hightstown Road
    East Windsor, NJ 08520

    Made in India

    Code: TS/DRUGS/22/2009

  • PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 1 x 5 Blister Carton

    AUROHEALTH

    NDC 58602-844-60

    *Compare to the active ingredients
    in Allegra-D® 24 Hour
    Allergy & Congestion Tablets

     Non-Drowsy


    Allergy & Congestion

    Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride
    Extended-Release Tablets USP 180 mg/240 mg

    Fexofenadine Hydrochloride 180 mg/antihistamine
    Pseudoephedrine Hydrochloride 240 mg/nasal decongestion

    24 HR

    Indoor / Outdoor Relief Of

    • Nasal and Sinus Congestion Due to Colds or Allergens
    • Sneezing; Runny Nose; Itchy, Watery Eyes and Itchy Nose or Throat Due to Allergies    

    Actual size
    5 Extended-Release Tablets
    PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 1 x 5 Blister Carton

  • INGREDIENTS AND APPEARANCE
    FEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE 
    fexofenadine hydrochloride and pseudoephedrine hydrochloride tablet, film coated, extended release
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:58602-844
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    FEXOFENADINE HYDROCHLORIDE (UNII: 2S068B75ZU) (FEXOFENADINE - UNII:E6582LOH6V) FEXOFENADINE HYDROCHLORIDE180 mg
    PSEUDOEPHEDRINE HYDROCHLORIDE (UNII: 6V9V2RYJ8N) (PSEUDOEPHEDRINE - UNII:7CUC9DDI9F) PSEUDOEPHEDRINE HYDROCHLORIDE240 mg
    Inactive Ingredients
    Ingredient NameStrength
    CELLULOSE ACETATE (UNII: 3J2P07GVB6)  
    SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
    COPOVIDONE K25-31 (UNII: D9C330MD8B)  
    CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  
    DIBUTYL SEBACATE (UNII: 4W5IH7FLNY)  
    FERROSOFERRIC OXIDE (UNII: XM0M87F357)  
    GLYCERYL MONO- AND DICAPRYLOCAPRATE (UNII: U72Q2I8C85)  
    HYPROMELLOSE 2208 (100000 MPA.S) (UNII: VM7F0B23ZI)  
    HYPROMELLOSE 2910 (3 MPA.S) (UNII: 0VUT3PMY82)  
    LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  
    MICROCRYSTALLINE CELLULOSE 200 (UNII: 5XDI2TS1EZ)  
    POLYETHYLENE GLYCOL 400 (UNII: B697894SGQ)  
    POLYVINYL ALCOHOL, UNSPECIFIED (UNII: 532B59J990)  
    PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
    SHELLAC (UNII: 46N107B71O)  
    SODIUM LAURYL SULFATE (UNII: 368GB5141J)  
    STEARIC ACID (UNII: 4ELV7Z65AP)  
    TALC (UNII: 7SEV7J4R1U)  
    TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  
    Product Characteristics
    ColorWHITE (white to off-white) Scoreno score
    ShapeROUND (biconvex with slightly blister surfaced) Size13mm
    FlavorImprint Code FES
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:58602-844-601 in 1 CARTON04/17/2025
    15 in 1 BLISTER PACK; Type 0: Not a Combination Product
    2NDC:58602-844-662 in 1 CARTON04/17/2025
    25 in 1 BLISTER PACK; Type 0: Not a Combination Product
    3NDC:58602-844-853 in 1 CARTON04/17/2025
    35 in 1 BLISTER PACK; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    ANDAANDA21523204/17/2025
    Labeler - Aurohealth LLC (078728447)
    Establishment
    NameAddressID/FEIBusiness Operations
    Aurobindo Pharma Limited650381903ANALYSIS(58602-844) , MANUFACTURE(58602-844)